On the weekly chart Oscar Health is building a broad base after a prolonged decline. Price has stabilized above a long-term rising trendline originating from the 2022 lows and is now trading back into a key area of interest where the market previously showed acceptance.
The technical focus is the 10.33–11.00 zone. This area aligns with the 0.618 Fibonacci retracement, weekly trendline support, and the 200-week moving average, making it structurally significant. The pullback into this zone is not accompanied by increasing downside momentum. ADX remains subdued, indicating a lack of trend pressure and pointing toward accumulation rather than distribution. Volume around this area is concentrated, suggesting active participation rather than passive sell-through.
Structurally, the move higher is built from a base rather than a vertical impulse. The first major reaction area above is located near 31.50, where the market previously paused and reversed on the higher timeframe. Acceptance above that level would open the path toward the next structural reaction zone near 44, which corresponds to the upper boundary of the multi-year structure. These are not forecasts, but logical reaction levels derived from market structure.
Fundamentally, the picture supports the long-term context. Revenue for Q3 2025 reached 2.92B USD, with Q4 2025 revenue estimated at 3.11B USD. EPS for Q3 came in at -0.53 USD, with Q4 estimated at -0.89 USD ahead of the upcoming earnings report. Cash flow remains positive, with operating cash flow TTM at 769.77M USD and free cash flow TTM at 735.64M USD. Valuation remains compressed, with price-to-sales at 0.29 and enterprise value at 3.49B USD.
As long as price holds this structural area, the market appears to be building a base rather than extending the prior downtrend. The question is not speed, but acceptance.
Sometimes insurance only pays off with time.
The technical focus is the 10.33–11.00 zone. This area aligns with the 0.618 Fibonacci retracement, weekly trendline support, and the 200-week moving average, making it structurally significant. The pullback into this zone is not accompanied by increasing downside momentum. ADX remains subdued, indicating a lack of trend pressure and pointing toward accumulation rather than distribution. Volume around this area is concentrated, suggesting active participation rather than passive sell-through.
Structurally, the move higher is built from a base rather than a vertical impulse. The first major reaction area above is located near 31.50, where the market previously paused and reversed on the higher timeframe. Acceptance above that level would open the path toward the next structural reaction zone near 44, which corresponds to the upper boundary of the multi-year structure. These are not forecasts, but logical reaction levels derived from market structure.
Fundamentally, the picture supports the long-term context. Revenue for Q3 2025 reached 2.92B USD, with Q4 2025 revenue estimated at 3.11B USD. EPS for Q3 came in at -0.53 USD, with Q4 estimated at -0.89 USD ahead of the upcoming earnings report. Cash flow remains positive, with operating cash flow TTM at 769.77M USD and free cash flow TTM at 735.64M USD. Valuation remains compressed, with price-to-sales at 0.29 and enterprise value at 3.49B USD.
As long as price holds this structural area, the market appears to be building a base rather than extending the prior downtrend. The question is not speed, but acceptance.
Sometimes insurance only pays off with time.
Trade fechado: objetivo atingido
OSCR deal closed by hand +150%
Наш канал: t.me/totoshkatradingteam
⏺ Брокеры которым доверяю:
FxPro - ib-fxpro.com/?ib=SwHtc7m3
AMarkets - profit-market.info/promo/?g=BZA6ZC
⏺ Брокеры которым доверяю:
FxPro - ib-fxpro.com/?ib=SwHtc7m3
AMarkets - profit-market.info/promo/?g=BZA6ZC
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Наш канал: t.me/totoshkatradingteam
⏺ Брокеры которым доверяю:
FxPro - ib-fxpro.com/?ib=SwHtc7m3
AMarkets - profit-market.info/promo/?g=BZA6ZC
⏺ Брокеры которым доверяю:
FxPro - ib-fxpro.com/?ib=SwHtc7m3
AMarkets - profit-market.info/promo/?g=BZA6ZC
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.